Autoimmune Gastropathy in Type 1 Diabetic Patients With Parietal Cell Antibodies: Histological and clinical findings

OBJECTIVE —Approximately 15–20% of type 1 diabetic patients exhibit parietal cell antibodies (PCAs) targeting gastric H + /K + ATPase. We examined whether iron deficiency anemia, pernicious anemia, and autoimmune gastritis, which may predispose to gastric tumors, were more frequent in PCA + than in PCA - patients. RESEARCH DESIGN AND METHODS —Gastric biopsies from 88 consecutively recruited type 1 diabetic patients (51 men and 37 women, 47 PCA + and 41 PCA - , aged 42 ± 13 years) were evaluated using the updated Sydney system. Immunostaining was done for parietal cells, B- and T-cells, enterochromaffin-like (ECL) cells, and Helicobacter pylori ( HP ). PCAs were assayed by indirect immunofluorescence, H + /K + ATPase antibodies by enzyme immunoassay, and HP by serology, urea breath test, and histology. Pentagastrin tests were performed in 42 subjects. RESULTS —Autoimmune gastritis (AG) was present in 57% of PCA + and 10% of PCA - cases (OR 12.5, P P = 0.04) and hypergastrinemia (β = 0.01; P = 0.026), but not HP , age, diabetes duration, sex, and HLA-DQ type were risk factors for AG. Iron deficiency anemia (OR 3.9, P = 0.015), pernicious anemia (OR = 4.6, P = 0.022), and hypochlorhydria (OR = 20.0, P = 0.0002) were more frequent in AG + individuals. HP infection was present in 47 patients but did not influence corpus histology or gastrinemia. (Pre)malignant lesions were found in 26% of PCA + subjects: ECL cell hyperplasia in 7 AG + patients, comprising 1 with a gastric carcinoid tumor, and corpus intestinal metaplasia in 11 AG + patients, including 1 with linitis plastica. CONCLUSIONS —PCA + type 1 diabetic patients should be screened for autoimmune gastritis, iron deficiency, and pernicious anemia. Particularly hypergastrinemic PCA + patients with autoimmune gastritis are at increased risk for (pre)malignant gastric lesions.